MAPK8 and Alzheimer disease: An increasing amount of evidence revealed the involvement of c-Jun N-terminal kinase (JNK), also known as stress-activated protein kinases, in a range of pathophysiological processes underlying AD (Mehan et al., 2011; Zhou et al., 2015).